We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Later this week activists will seek permission in federal court to gain access to White House documents and to depose a former administration adviser concerning the controversial contraceptive Plan B to determine whether the White House interfered in the FDA’s decisionmaking on the drug.
An FDA advisory committee is recommending Bayer Pharmaceutical’s blood-loss treatment Trasylol as safe and effective, despite an earlier agency public health warning.
The FDA’s recent decision to drop an advisory panel member shows that the agency uses a double standard in applying its conflict-of-interest policies, activists say.
Merck could see a boost in Gardasil prescriptions if a Michigan state legislative proposal requiring all girls entering sixth grade to receive vaccinations against the sexually-transmitted human papillomavirus (HPV) is successful.
For patients who have recently suffered a heart attack, Pfizer’s Lipitor may reduce the risk of a recurrence by 46 percent compared with Zocor, according to trial results released Sept. 6 by Pfizer.
The failed Plavix settlement appears to have led to the forced departure of Bristol-Myers Squibb (BMS) CEO Peter Dolan and Senior Vice President and General Counsel Richard Willard on the recommendation of a federal monitor.
The FDA is requesting that Genentech provide an update of the company’s clinical data for the use of Avastin to treat breast cancer, the company announced Sept. 11.